Catalyst Pharmaceuticals (CPRX) Cash & Equivalents Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 42.79% |
| Dec 31, 2025 | 40.35% |
| Sep 30, 2025 | 42.57% |
| Jun 30, 2025 | 41.51% |
| Mar 31, 2025 | 41.67% |
| Dec 31, 2024 | 42.04% |
| Sep 30, 2024 | 57.96% |
| Jun 30, 2024 | 74.20% |
| Mar 31, 2024 | 74.69% |
| Dec 31, 2023 | 52.74% |
| Sep 30, 2023 | 62.68% |
| Jun 30, 2023 | 78.42% |
| Mar 31, 2023 | 49.88% |
| Dec 31, 2022 | 39.00% |
| Sep 30, 2022 | 103.55% |
| Jun 30, 2022 | 89.71% |
| Mar 31, 2022 | 78.00% |
| Dec 31, 2021 | 65.30% |
| Sep 30, 2021 | 54.41% |
| Jun 30, 2021 | 48.53% |
| Mar 31, 2021 | 41.78% |
| Dec 31, 2020 | 35.77% |
| Sep 30, 2020 | 29.02% |
| Jun 30, 2020 | 25.32% |
| Mar 31, 2020 | 19.75% |
| Dec 31, 2019 | 57.98% |
| Sep 30, 2019 | 31.91% |
| Jun 30, 2019 | 9.61% |
| Mar 31, 2019 | 77.85% |
| Dec 31, 2018 | 49.52% |
| Sep 30, 2018 | -3.92% |
| Jun 30, 2018 | 62.26% |
| Mar 31, 2018 | 97.88% |
| Dec 31, 2017 | 109.94% |
| Sep 30, 2017 | -9.35% |
| Jun 30, 2017 | 2.70% |
| Mar 31, 2017 | 16.14% |
| Dec 31, 2016 | 18.17% |
| Sep 30, 2016 | 52.32% |
| Jun 30, 2016 | 40.60% |
| Mar 31, 2016 | 26.46% |
| Dec 31, 2015 | 38.83% |
| Sep 30, 2015 | 39.29% |